Delivery Order SPE2DB22D2006-SPE2DB23FV9KL

Award Date 4/27/23
Potential Completion Date 4/28/23
Potential Value $22K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Triumeq 600-50-300 mg tablets. The $67,089.96 firm fixed-price delivery order falls under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen holds with the DLA Troop Support Medical. This IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $80,352.58, is for the delivery of TRIUMEQ 600-50-300 MG TABLET medical products. The award is a delivery order under an Indefinite Delivery Contract (IDC) that Amerisourcebergen's parent company, Cencora, Inc., holds with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of TRIUMEQ 600-50-300 MG TABLET in 30-count packages. The $3,326.83 firm-fixed price delivery order falls under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as the primary vehicle for the company to provide a wide range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of TRIUMEQ 600-50-300 MG TABLET. The contract, valued at $13,394.17, is a firm fixed-price delivery order with a completion date of February 27, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $86,023.36, is for the delivery of Triumeq 600-50-300 mg tablets, a specialty pharmaceutical product, to support military and veterans' healthcare programs. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen's parent company,...
This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency of the U.S. Department of Defense, to Amerisourcebergen Drug Corp's Corporate Office Division. The $9,772.38 firm fixed-price delivery order is for the supply of TRIUMEQ 600-50-300 MG TABLET medication. This award falls under Amerisourcebergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. The IDC enables DLA to efficiently...
This federal contract award, valued at $10,356.99, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is a delivery order for TRIUMEQ 600-50-300 MG TABLET UU 30S, a pharmaceutical product. The contract has a firm fixed price and an ultimate completion date of December 9, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products...
This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $22,530.42 firm-fixed-price delivery order is for the supply of TRIUMEQ 600-50-300 MG TABLET, a medication. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, which covers a wide range of pharmaceutical products and medical supplies...
This federal contract award involves the delivery of pharmaceutical products and medical supplies from Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, with a ceiling value of $14,301.00, covers the delivery of TRIUMEQ 600-50-300 MG TABLET medication. This is a delivery order awarded under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA, valued at up to $999,999,999.00 and running...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $98,570.42, is a delivery order for the supply of TRIUMEQ 600-50-300 MG TABLET, a pharmaceutical product. This award is part of a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. (the parent company of Amerisourcebergen Drug Corp) and the DLA Troop Support Medical, valued at up to...
  • SPE2DB22D2006
    Indefinite Delivery Contract
  • SPE2DB22D2006-SPE2DB23FV9KL
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the delivery of Triumeq tablets. The $21,590.42 firm fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) between the DLA Troop Support Medical and Cencora, Inc. (doing business as Amerisourcebergen), valued at up to $999,999,999.00 through November 2026. This single-award IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, and other critical medical commodities to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen's extensive expertise in pharmaceutical distribution and its extensive supply chain capabilities make it a key vendor for the DLA and other federal agencies in meeting the diverse healthcare needs of the military, veterans, and other government beneficiaries.

Generated 5/9/25, 10:08 AM